GeneBioTech Co. ,Ltd (KOSDAQ:086060)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,130.00
-50.00 (-0.97%)
At close: Mar 6, 2026
61.83%
Market Cap 43.31B
Revenue (ttm) 92.28B
Net Income (ttm) 3.68B
Shares Out 8.61M
EPS (ttm) 427.53
PE Ratio 11.77
Forward PE n/a
Dividend 50.00 (0.97%)
Ex-Dividend Date Dec 29, 2025
Volume 79,839
Average Volume 496,558
Open 5,180.00
Previous Close 5,180.00
Day's Range 4,990.00 - 5,200.00
52-Week Range 3,015.00 - 5,990.00
Beta 0.57
RSI 57.08
Earnings Date Mar 13, 2026

About GeneBioTech Co. ,Ltd

GeneBioTech Co. ,Ltd, together with its subsidiaries, engages in the manufacture and sale of feed additives and functional food in South Korea. It also manufactures and sells animal drugs. The company was founded in 2000 and is headquartered in Gongju-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 2000
Employees 42
Stock Exchange KOSDAQ
Ticker Symbol 086060
Full Company Profile

Financial Performance

In 2024, GeneBioTech Co. ,Ltd's revenue was 82.96 billion, an increase of 4.38% compared to the previous year's 79.48 billion. Earnings were 2.87 billion, an increase of 10.57%.

Financial Statements

News

There is no news available yet.